ROSE-MARY MBIBONG-MABO, DPM
Public Medicine Podiatrist in ATLANTA, Georgia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ROSE-MARY MBIBONG-MABO, DPM filed 288 Medicare Part D claims in 2023 as a Public Medicine Podiatrist in ATLANTA, Georgia.
- 288
- Part D claims, 2023
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ROSE-MARY MBIBONG-MABO, DPM's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
288 49th percentile higher than 49% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about ROSE-MARY MBIBONG-MABO, DPM?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Georgia
How Public Medicine Podiatrist compares to other specialties among Georgia providers
Public Medicine Podiatrist share within Georgia
Public Medicine Podiatrist is one of the more visible NUCC categories in Georgia
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Public Medicine Podiatrist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Public Medicine Podiatrist ABMS/AOA estimate
Est. board-certified rate (Public Medicine Podiatrist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Public Medicine Podiatrist US NPIs
Specialty board-certified rate — Public Medicine Podiatrist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ROSE-MARY MBIBONG-MABO, DPM appears in the CMS NPPES registry as a Public Medicine Podiatrist provider holding DPM credentials at 315 BOULEVARD NE STE 532, ATLANTA, GA, 30312, with a listed phone of (770) 284-1616. NPI 1851703078 was issued on 05/22/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MBIBONG-MABO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 288 prescription claims written by this provider, covering 96 Medicare beneficiaries and totaling roughly $9K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Public Medicine Podiatrist is a narrow specialty nationwide, with 45 enrolled providers across 22 states and an average of 311 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1851703078 |
|---|---|
| Specialty | Public Medicine Podiatrist |
| Credentials | DPM |
| Gender | Female |
| NPI Issued | 05/22/2014 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ROSE-MARY MBIBONG-MABO, DPM's current license status, disciplinary history, and board certifications with the Georgia Composite Medical Board in Georgia before relying on this page for a clinical or care decision.
How we sourced this profile
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 354
- Total Day Supply
- 9,453
- Generic Drug Cost
- $8K
- Antibiotic Claims
- 18
Patient Demographics
- Average Patient Age
- 69.5 years
- Avg HCC Risk Score
- 1.83
- Gender Split
- 53% female / 47% male
- Age Distribution
- <65: 20, 65-74: 53, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ROSE-MARY MBIBONG-MABO, DPM prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ketoconazole
Ketoconazole
97 claims
- Ciclopirox 37
Ciclopirox
37 claims
- Clotrimazole 37
Clotrimazole
37 claims
- Diclofenac Sodium 26
Diclofenac Sodium
26 claims
- Terbinafine Hcl 22
Terbinafine Hcl
22 claims
- Ammonium Lactate 21
Ammonium Lactate
21 claims
| Drug | Claims |
|---|---|
| Ketoconazole | 97 |
| Ciclopirox | 37 |
| Clotrimazole | 37 |
| Diclofenac Sodium | 26 |
| Terbinafine Hcl | 22 |
| Ammonium Lactate | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Public Medicine Podiatrist Overview
How ROSE-MARY MBIBONG-MABO, DPM fits within the Public Medicine Podiatrist landscape nationally.
ROSE-MARY MBIBONG-MABO, DPM's 288 claims are below the specialty average of 311.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Georgia
Frequently Asked Questions
What is ROSE-MARY MBIBONG-MABO, DPM's specialty? ▼
How much does ROSE-MARY MBIBONG-MABO, DPM prescribe under Medicare Part D? ▼
Where is ROSE-MARY MBIBONG-MABO, DPM located? ▼
What is ROSE-MARY MBIBONG-MABO, DPM's NPI number? ▼
How many Public Medicine Podiatrist providers are there in the US? ▼
What drugs does ROSE-MARY MBIBONG-MABO, DPM prescribe most often? ▼
Does ROSE-MARY MBIBONG-MABO, DPM accept Medicare? ▼
How can I verify ROSE-MARY MBIBONG-MABO, DPM's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology